Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Yichang Hec Changjiang Pharm
1558YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People's Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. The company's products are Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It has a strategic cooperation framework agreement with Jointown Pharmaceutical Group Co., Ltd., as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. Address: No. 38, Binjiang Road, Yichang, China
Analytics
Precio Objetivo de WallStreet
120.27 HKDRelación P/E
4.3971Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave 1558
Análisis de dividendos 1558
Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
44 %Tendencia del payout 1558
Valoración de la acción 1558
Finanzas 1558
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |